The possibility for developing a vaccine against leprosy has become a feasible one due to two significant recent findings: first, the availability of significant amounts of human lepra bacilli from the armadillo and, second, methods for their purification from leprous tissues. To evaluate the potential usefulness of such purified armadillo-grown human Mycobacterium leprae, it is first necessary to demonstrate that it retains the capability of inducing delayed-type hypersensitivity in experimental animals under appropriate conditions which could be used in humans and that such M. leprae preparations fail to sensitize to tissue components. As part of the IMMLEP Program of the -Special Program for Research and Training in Tropical Diseases of the World Health Organization, we have been able to study the conditions required to fulfill these requirements in guinea pigs. A variety of regimens in terms of dose, route of administration, adjuvants, and specificity were studied, and the results indicate that armadillo-grown and purified M. leprae have an ability to engender high levels of delayed-type hypersensitivity in normal guinea pigs in the absence of oil adju-788 MEHRA AND BLOOM and emulsified in oil). Other adjuvants used were biodegradable adjuvant (adjuvant 65) with peanut oil (prepared by the method of Peck et al. [6] ), cord factor, and muramyldipeptide (MDP) obtained from E. Lederer (Centre National de la Recherche Scientifique, Institut de Chimie des Substances Naturelles, Gif-Sur-Yvette, France).
Animals received 0.5 mg of M. leprae either in four footpads (oil suspensions) or intradermally (0.1 ml/ site) in five sites on the flank above the foreleg.
Skin tests. The animals were tested with 6, 0. Results are expressed as a stimulation index (experimental counts per minute/control counts per minute).
Enumeration of antigen-sensitive cells. Enumeration of antigen-sensitive T-cells was carried out by the virus plaque assay (2) . This technique measures the ability of antigen-sensitive T-cells to permit replication of vesicular stomatitis virus after they are activated by the specific antigen. In brief, after peripheral blood mononuclear cells had been cultured in the presence and absence of mitogens or antigens in culture tubes for 3 days, they were infected with vesicular stomatitis virus at a multiplicity of 10 plaque-forming units per cell for 2 h. The excess virus was removed and neutralized with anti-vesicular stomatitis virus. Each sample was plated in three dilutions on L-cells. Plates were overlaid with 1% agar in minimal essential medium containing 6% fetal calf serum and incubated for 2 days. At the end of the incubation period the plates were fixed and stained to count plaques. The results are expressed as plaque-forming cells per 103 cells in stimulated cultures above the background in unstimulated control cultures.
RESULTS
Comparison of sensitization of guinea pigs with intact or sonically treated M. leprae in aqueous or oil vehicles. The initial series of studies compared the ability of a constant amount of M. leprae (0.5 mg) to induce delayed-type hypersensitivity in normal guinea pigs. To assess the degree and specificity of sensitization, animals so immunized were tested intradermally approximately 1 month after sen- (8) .
As a result of these experiments, we infer that the optimal procedure for sensitization of guinea pigs to M. leprae is intradermal inoculation of autoclaved intact bacilli suspended in aqueous media in multiple sites.
Comparison of route of immunization and the effect of multiple sensitization inoculations. As Fig. 3 shows, comparison of the intradermal route with the footpad inoculation route for sensitizing guinea pigs with intact bacilli suspended in aqueous suspension indicated that, although both were effective, the intrader-I mal route appeared to be somewhat more effec-16 *C 0 t + +'---tive. When animals sensitized to 0.5 mg were !a pigs with M. leprae boosted at intervals of 1 week to 1 month after -s. Animals were im-initial sensitization, only a very slight increase 'leprae suspended in in degree of skin test reactivity was observed, saline suspension of suggesting that a single inoculation was effective . A group of guinea in inducing delayed-type hypersensitivity in M. leprae autoclaved guinea pigs. ,inea pig received 0. 5 Use of living BCG and other mycobacte-)otpads (fp) or intra-rial products as adjuvants. Because of the Edermal injections of well-known sensitizing and adjuvant properties nkL (Phnne, theo fnrn.,1n
In addition to skin testing with M. leprae, soluble antigen AB19, and PPD, animals in two groups were skin tested with 0. (Fig. 6) .
Duration of sensitization. Groups of six animals were immunized with M. leprae in Hanks solution, adjuvant 65, or IFA or M. leprae together with BCG. The animals were maintained without further contact with M. leprae antigens for a period of 1 year and then skin tested with the above battery of antigens. The results (Fig. 7) Histology of the skin test sites. small differences among the sensitization with M. leprae suspended in IFA, M. leprae suspended in saline and emulsified in IFA, or M. leprae emulsified in adjuvant 65. They were all effective in sensitization but, in fact, were no better than bacilli suspended in Hanks solution or saline. Other studies also showed that irradiated M. leprae in aqueous suspension produced greater delayed-type hypersensitivity response than did a water-in-oil emulsion in mice (5). The possibility of using living BCG as an adjuvant was also explored. Guinea pigs immunized with M. leprae together with BCG (106 or 107 viable organisms) showed significant sensitization, but again the level was no better than in guinea pigs immunized intradermally with M. leprae alone. Thus, M. leprae appears to be a remarkably strong immunogen for cell-mediated immunity, and addition of BCG fails to enhance the sensitization significantly. Similarly, the absence of an adjuvant effect of BCG on M. leprae in immunization has been observed in mice (7) .
Animals immunized with M. leprae alone showed quite strong reactivity to PPD, indicating marked cross-sensitization to other mycobacterial antigens. Numerous attempts to establish M. leprae specificity by carrying out a series of skin test antigen dilution studies failed; there were no dilutions of antigen at which PPD reactivity was absent and reactivity to M. leprae or the soluble antigen was retained. Thus, it must be concluded that M. leprae has sufficient antigenic cross-reactivity that sensitization to unique antigens of M. leprae and cross-reacting antigens shared with M. tuberculosis occurs simultaneously. On the other hand, the soluble M. leprae skin test antigen of Draper and Rees was remarkably M. leprae specific and demonstrated no skin reactivity in guinea pigs immunized with BCG alone. This specificity of the soluble M. leprae extract for sensitization with M. leprae suggests that this may well be a useful test antigen for M. leprae sensitization in humans.
In vitro studies on lymphocyte transformation and the virus plaque assay for enumerating activated T-cells indicated that M. leprae in saline was an excellent sensitizer and an effective eliciting antigen. Of interest is the fact that the number of antigen-reactive cells found in peripheral blood (1.4%) is comparable to that found in guinea pig lymph nodes sensitized with M. tuberculosis in adjuvant (2) .
Even though the bacilli we received were killed by irradiation, it might be preferable to use bacilli sterilized by autoclaving before use, and our results indicate that immunization with autoclaved M. leprae was, surprisingly, as good or better than that with bacilli not subjected to autoclaving, a phenomenon also observed by Shepard et al. in mice (8) .
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